Need Help? Call 1­-866-­796-­7386
« back to stock screener

  VIVO stock: Meridian Bioscience, Inc.

Current Rating
Buy

Previous Rating

Buy
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$17.49
Market Cap
1.07B
Sector
Health Care
Div. Growth
-100.00%
P/E
49.2
P/B
5.13
P/S
5.14
Dividend %
-
P/CF
-
P/FCF
38.6
Op. Cash Flow
30.5K
FCF
0.6
Op. Margin
14.40%
Net Margin
10.50%
ROE
10.90%
ROI
9.60%
ROA
6.50%
EPS Growth
-22.80%
Current Ratio
6.9
Debt/Equity
39.70%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Teva Pharmaceutical Industries (TEVA) $11.72 - - 12.39B Strong Buy
Digirad Corporation (DRAD) $3.34 - - 12.6M Strong Buy
Pacific Biosciences of Califor (PACB) $4.47 - - 581.8M Strong Buy
Amneal Pharmaceuticals Inc (AMRX) $4.22 - - 1.31B Strong Buy
Daxor Corporation (DXR) $16.79 - - 69.3M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More